Key result
MTNR1B rs724030 G allele linked to ~0.03 mmol/L higher fasting glucose and decreased islet function.
Why the study?
To investigate the associations between the MTNR1B rs724030 A>G variant and prediabetes risk, glycemic traits, and lipid levels, and determine potential sex dimorphisms in islet function and insulin resistance.
Is the MTNR1B rs724030 A>G variant associated with prediabetes risk and altered islet function in healthy and prediabetic individuals?
Observational (n=5,159)
Is the MTNR1B rs724030 A>G variant associated with prediabetes risk and altered islet function in healthy and prediabetic individuals?
The MTNR1B rs724030 variant is associated with altered glycemic traits and islet function in a sex- and adiposity-dependent manner among individuals with normal glucose tolerance.
Answers are grounded in this paper and cite their sources.
Does not support MTNR1B genotyping for prediabetes screening; leaves open causal role in progression among lean adults.
Objective This study aims to investigate the associations between MTNR1B rs724030 A>G variant and prediabetes risk, along with their correlations with clinical features, including plasma glucose and serum insulin levels during oral glucose tolerance test (OGTT), islet function, insulin resistance, and plasma lipid levels. In particular, we investigated whether there are sex dimorphisms in the impact of this variant on islet function/insulin resistance. Methods We included 3415 glucose-tolerant healthy and 1744 prediabetes individuals based on OGTT. Binary logistic regression was performed to evaluate the relationships between rs724030 in MTNR1B and prediabetes under the additive model. Additionally, multiple linear regression was utilized to investigate the associations between this variant and glycemic-related quantitative traits and lipid levels. Results While no association was observed between the rs724030 variant in MTNR1B and prediabetes risk in the overall cohort (P > 0.05), we found the G allele of this variant was associated with higher fasting and 30-minute plasma glucose levels, decreased Insulinogenic Index (IGI), and oral disposition index (DIo) (P = 0.009, 0.001, 0.001, and 0.007, respectively) in the normal glucose tolerance (NGT) individuals with normal BMI levels. Furthermore, we also found significant associations between this variant and IGI, corrected insulin response (CIR), and DIo (All P < 0.001) in female individuals whose waist-to-hip ratio (WHR) is greater than 0.85, with considerable heterogeneity (Phet = 0.009, 0.030, and 0.049, respectively) to male participants in the NGT individuals, but not in the impaired fasting glucose (IFG)/impaired glucose tolerance (IGT) individuals. Additionally, no association was observed between this variant and insulin clearance (All P > 0.05). Conclusions The MTNR1B rs724030 variant contributes to glycemic traits and islet function, and its effects have sex dimorphisms in the NGT individuals after stratifying by WHR. All these findings provide a basis for accurately assessing islet function in healthy populations and offer a new perspective on precision prevention.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2025) conducted an observational in Normal glucose tolerance and prediabetes (n=5,159). MTNR1B rs724030 A>G variant vs. AA genotype (non-carriers) was evaluated on Fasting plasma glucose levels in normal glucose tolerance individuals with normal BMI (MD 0.029, 95% CI 0.007-0.050, p=0.009). The MTNR1B rs724030 G allele was associated with a per-allele increase of 0.029 mmol/L in fasting plasma glucose and decreased islet function in normal glucose tolerance individuals with normal BMI.
Synapse has enriched 10 related papers. Consider them for comparative context: